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1. Introduction 
In contrast to visceral solid-organ transplants, a vascularized composite tissue allograft 
(CTA) is not a single tissue, and is histologically heterogeneous. It is a neurovascularized 
module of nonvital tissues which include structural, functional and aesthetic units. CTAs 
are composed of a large spectrum of ectodermal tissues: epidermis and epidermal 
derivatives such as nails and hair, nerves and mesodermal tissues such as dermis, muscles, 
bones, articular cartilage, ligaments, tendons and paratenon and other supportive and 
connective tissues, adipose tissue, vessels. In addition there are hematopoietic tissues and 
cells from bone marrow and lymph nodes and these latter elements are immunocompetent. 
Each tissue has differing antigenicity, displays different antigen expression and presentation 
mechanisms. As a result, CTAs elicit nonsynchronized immune responses, of differing 
intensity, among their tissue components. 
So far only 135 CTA transplantations were carried out on human patients: 68 hand 
transplantations (49 patients), 12 abdominal wall transplantations, 9 bone and vascularized 
articulations transplantations, 7 peripheral nerves, 2 tendons, 23 larynxes, 1 right abdominal 
muscle, 1 tongue, a lobe made of the cephalic cervical skin and 2 ears, and 11 faces.  
The transplantation of a composite tissue allograft is only justified when excellent functional 
outcome can be achieved. This aim is more important for CTAs then for organ allografts as 
the procedure is not lifesaving and lifelong immunosuppressive therapy, with its associated 
risks and side effects, is difficult to justify. Even mild and reversible rejection episodes can 
decrease the chance of a favorable outcome. 
Skin is an important component of a CTA and is the most immunogenic of the component 
tissues. The skin is more sensitive to rejection than any other tissues or visceral organ, and 
the primary reason is probably its unique immunologic defense function, with its special 
intrinsec antigenic and immunologic properties. Boss et al. identified these properties as "the 
skin immune system” and demonstrate, that the skin is not only the largest organ in the 
body but is itself an immunologic effector organ, with almost half its cells belonging or 
related to the immune system (especially the large quantity of dendritic cells within epider-
mis and dermis). For CTAs the best marker of rejection is by visual and histopathological 
examination of the skin, as it is the skin that is first involved in the rejection process. 
Skin is an important component of a CTA and is the most immunogenic of the component 
tissues. The skin is more sensitive to rejection than any other tissues or visceral organ, and 
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the primary reason is probably its unique immunologic defense function, with its special 
intrinsec antigenic and immunologic properties. Boss et al. identified these properties as "the 
skin immune system” and demonstrate, that the skin is not only the largest organ in the 
body but is itself an immunologic effector organ, with almost half its cells belonging or 
related to the immune system (especially the large quantity of dendritic cells within epider-
mis and dermis). For CTAs the best marker of rejection is by visual and histopathological 
examination of the skin, as it is the skin that is first involved in the rejection process.  
Monitoring of CTA rejection is facilitated because the first tissue to be rejected is the skin, 
which is the outermost tissue of a CTA. Skin biopsy provides a more specific diagnosis to 
confirm the visual assessment but delays diagnosis. Repeated skin biopsies also lead to 
scarring that represents a considerable aesthetic problem in the case of a hand or face 
transplants. The ideal marker of CTA rejection should therefore obviate the need for biopsy 
of the transplant and provide easily warning of rejection of the graft itself. Early detection of 
the first stages of rejection enables advanced administration of salvage therapy, resulting in 
a rapid and efficient reversal of rejection. 
2. Distant sentinel skin allograft (DSSG) - experimental study 
Some studies report a more rapid rejection of isolated skin grafts compared to rejection of 
skin that is part of a CTA. This has led us to examine the use of distant sentinel skin allograft 
(DSSG) of donor origin transplanted simultaneously with a limb, as a marker of rejection.  
In one of our studies, using a hind limb transplantation model in rats we demonstrated that 
the DSSG serves as a predictive marker for visual assessment, as well as a site for repeated 
biopsies that does not damage the CTA itself.  
Sixty rats with hind limb transplants were included in this study. They were divided into 
two groups. Group 1 (n=15) received limb transplants and immunosuppressive therapy 
(control group). Group 2 (n=45) received a limb transplant and a simultaneous sentinel skin 
graft, plus immunosuppressive therapy.  
Surgical procedure 
Brown Norway (BN) rats served as donors and Lewis rats as recipients of orthotopic hind 
limb transplants and free skin flap allografts. The previously described surgical technique 
for limb replantation and transplantation was used.7-11 A free full thickness skin graft 4 cm x 
5 cm was obtain from the abdominal region of BN donors and transplanted to the inter 
 
 
Fig. 1. Full thickness sentinel skin allograft and the hind limb transplantation 
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scapular region of LEW recipient rats. Special attention was given to preserve the 
panniculus carnosus and to apply the skin graft directly to this highly vascular tissue (Fig 1). 
A-F 4 x 5 cm full thickness skin graft harvested from the abdominal region of BN donor. 
DSSG transplanted to the inter-scapular region of LEW recipient rats. Special attention was 
given to preserve the panniculus carnosus (D) and to apply the skin graft on this highly 
vascular tissue. G, H The hind limb allotransplant 
Immunosuppressive drug regime 
All animals received standard immunosuppressive therapy, consisting of the triple drug 
combination with the first administration provided on the operative day. We used the stan-
dard regime consisting of FK506 (PrografR Janssen-Cilag) 2 mg/kg/ day; MMF (CellCeptR, 
Roche Products) 15 mg/kg/day and Prednisone (PredMixR, oral liquid 5 mg/ml. Archpend) 
0.5 mg/kg/day administered in 1 ml saline by oral gavage for 6 weeks. This time was 
sufficient to allow for complete healing of the skin graft and limb transplant, after which, all 
drugs were stopped. Salvage therapy was administered for early rejection episodes upon the 
first visual signs of rejection of the sentinel skin graft or of the transplanted limb skin. This 
consisted of FK506 10 mg/kg/day; MMF30 mg/kg/day and Prednisone 0.5 mg/kg/day. 
Salvage therapy was administered for 3 days, followed by the optimal drug regime until 
signs of rejection were reversed.  
Visual monitoring of rejection  
The skin of transplanted limbs and skin allografts was monitored twice a day for any signs 
of rejection, including erythema, changes in texture of the skin, desquamation, 
epidermolysis, edema, exudation and skin necrosis. After the withdrawal of 
immunosuppression rejection was assessed based on a new clinical (visual) and histologic 
grading system that was focused to more accurately describes the very early signs of skin 
rejection. Rejection was assigned visually, based on changes in color and texture of the skin 
in most clinically affected skin area.  
Histological evaluation of the rejection  
Tissue specimens were taken after withdrawal of immunosuppressive therapy, at the first 
signs of skin graft or limb skin rejection. Skin biopsies were fixed in 10% Neutral Buffered 
Formalin before transfer to 70% ethyl alcohol. Tissue samples were embedded in paraffin for 
routine light histological examination. Sections were stained with hematoxylin and eosin. A 
pathologist (CAL) read all the slides in a blinded fashion and scored the sections based on a 
proprietary histologic grading system. Rejection was assigned histologically, based on 
changes in the most immunoactive zone on the histological slides. 
3. Results 
One month post-operatively the skin grafts were well healed, with stable size and shape. To 
facilitate observation, hair from the skin graft and limb was removed with a depilatory 
cream at the end of the 6th postoperative week. This caused only a slight skin inflammation 
observed for one day in 3 rats.  
Visual rejection episodes in controls  
After the withdrawal of immunosuppression rejection was assessed based on a newly 
developed clinical (visual) and histologic grading system that was aimed to more accurately 
describes the very early signs of skin rejection. Rejection was assigned visually and 
histologically, based on changes in color and texture of the skin in most clinically affected 
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skin area and in the most immunoactive zone on the histological slides. The details of this 
visual scoring system are shown in (Table 1).   
 
Grade 0  
No rejection  
 Normal epidermal and dermal appearance without evidence of 
rejection  
Grade 1  
Indeterminate/  
supposed 
rejection  
Very early visual signs of rejection  
Focal (25% of limb or DSSG surface) inconspicuous changes in the 
skin color (pink/pinkish or slight red/reddish spots) and/or in the 
texture of the skin (dryness, fine scaling of epidermis)  
Grade 2  
Mild rejection  
Clear visual signs of rejection  
Diffuse (25-50 % of DSSG or limb skin surface) clear changes in color 
and texture of skin, sometimes with slight limb edema, thickening of 
the skin  
Grade 3  
Moderate 
rejection  
 Extensive (more than 50% of DSSG or limb skin surface) and 
advances alteration of skin quality – desquamation, scabs, skin crusts 
Grade 4  
Severe rejection  
 Destruction of epidermis with intact dermis or complete destruction 
of the skin  
Table 1. Visual grading system for assessment of rejection 
Three animals (20%) showed early rejection and salvage therapy was successful in all cases. 
One of rats developed a second rejection episode, successfully treated with salvage therapy. 
In two of these three rats skin damage after resolution of rejection prevented assessment of 
grades 1 and 2 rejection do to incomplete or deficient healing. The remaining 12 rats (80%) 
were free of rejection during the treatment period.  
The average time for the onset of grade 1 rejection in limb skin after immunosuppression 
ceased was 6.75 ± 1.42 days (median day 6.5) and 8.75 ± 2.38 days (median day 8) for grade 
2. The mean interval between the onset of grade 1 and the development of grade 2 rejection 
in limb skin was 2 ± 1.35 days for rats free of early rejection (n= 12).  
Visual rejection episodes in group 2 (rats with limb transplant and DSSG)  
During the first 6 weeks 28 rats (62%) were rejection free. Seventeen rats (38%) developed 
early rejection. Thirteen rats (29%) were excluded from the study due to the poor quality of 
skin doe to incomplete or deficient healing after salvage therapy. In total, 32 rats, 28 without 
early rejection episodes and 4 rats with one episode of very early or early rejection, 
successfully reversed with salvage therapy, were evaluated after termination of im-
munosuppressive therapy (Fig 2).  
The average onset grade 1 rejection was 5.06 days (median day 5) for DSSG, and 6.41 days 
(median day 6) for limb skin. The average interval between grade 1 rejection of the skin graft 
and grade 1 rejection of the limb skin was 1.35 days. Rats evaluated in group 2 displayed a 
strong statistic difference in the onset of grade 1 rejection of the skin graft and the limb skin 
(p < 0.0005).  
The average onset grade 2 rejection was 8.28 days (median day 8) for DSSG, and day 9.21 7 
(median day 9) for limb skin. The interval between grade 2 rejection of the skin graft and 
grade 2 rejection of the limb skin was 0.91 days. There was a small but statistically 
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significant difference between the first day with visual signs of grade 2 rejection of the skin 
graft and the limb skin (p < 0.05).  
 
  
 
 
 
 
 
Fig. 2. Clinical (visual) aspect of rejection on the limb skin and on the DSSG in the earlier 
stages of rejection A, B,C Grade 0 (No rejection) - Normal epidermal and dermal appearance 
without evidence of rejection D, E, F Grade 1 (Inconspicuous / indeterminate / supposed rejection) 
- Very early visual signs of rejection; Focal (25% of limb or DSSG surface) inconspicuous 
changes in the skin color (pink/pinkish or slight red/reddish spots) and/or in the texture of 
the skin (dryness, fine scaling of epidermis) G, H, I Grade 2 (Mild rejection) - Clear visual 
signs of rejection; Diffuse (25-50 % of DSSG or limb skin surface) clear changes in color and 
texture of skin, sometimes with slight limb edema, thickening of the skin 
The time difference between the onset of grade 1 rejection and the development of grade 2 
rejection was on average 3.4 days for DSSG and 2.9 days for limb skin. There was no 
significant difference between grades 1 or 2 rejection of the limb skin of control animals and 
rats with both a limb transplant and sentinel skin graft. As a result, we conclude that appli-
cation of a skin allograft does not influence the rejection of a transplanted limb.  
Histologic rejection results  
161 biopsies from 45 animals were evaluated histologically for signs of rejection. Specimens 
were taken for suspected rejection or when the visual grade appeared to alter. Samples were 
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taken concurrently, from both the sentinel skin graft and limb allograft. Rejection was 
assigned histologically, based on changes in the most immunoactive zone on the histological 
slides. All slides were analyzed in a blinded fashion and scored based on a new histologic 
grading system. The new grading system was introduced to describe the very early changes 
in skin pathology observed during onset of rejection. The criteria used for histologic 
assessment of skin rejection are shown in (Table 2, Fig 3).  
 
 
 
 
 
Grade 0  
Normal epidermal and dermal appearance without evidence of 
rejection  
Dermal mononuclear cell infiltration < 10 cells / 500X optic field  
Grade 1  
Indeterminate 
rejection  
Dermal mononuclear cell infiltration 10-20 cells / 500X optic field  
Epidermal (especially on epidermo-dermal junction) mononuclear 
cells infiltration  1-3 cells / 200X optic field   
Grade 2  
Mild rejection  
Diffuse intercellular edema (spongiosis) on basal layer of epidermis 
with normal continuity of epidermo-dermal junction  
Dermal mononuclear cell infiltration 10-20 cells / 500X optic field  
Epidermal (especially on epidermo-dermal junction) mononuclear 
cells infiltration  > 3 cells / 200X optic field   
Grade 3  
Moderate 
rejection  
Discontinuity of epidermo-dermal junction  
Focal basal cells vacuolization  
Dermal mononuclear cell infiltration more than 20 cells / 500X optic 
field  
Epidermal (especially on epidermo-dermal junction) mononuclear 
cells infiltration  > 3 cells / 200X optic field   
Intercellular edema on basal layer of epidermis (spongiosis)  
Dyskeratosis of squamous cells in the epidermis or hair follicle 
epithelium   
Grade 4  
Severe rejection  
Complete separation at the epidermo dermal junction  
Complete epidermal degeneration and necrosis  
Dense inflammatory infiltration in the dermis > 20 cells / 500X optic 
field  
 
 
 
 
 
Table 2. Histology grading and scoring system for assessment of rejection 
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Fig. 3. Histological aspects of rejection in the earlier stages of skin rejection 
A, B Grade 0 (H&E; 200x and 500x) Normal epidermal and dermal appearance without evidence of 
rejection - Dermal mononuclear cell infiltration < 10 cells / 500X optic field C, D Grade 1 
(H&E; 200x and 500x) Indeterminate rejection - Dermal mononuclear cell infiltration 10-20 
cells / 500X optic field; Epidermal (especially on epidermo-dermal junction) mononuclear 
cells infiltration  1-3 cells / 200X optic field  E, G. Grade 2 (H&E; 200x and 500x) Mild 
rejection - Diffuse intercellular edema (spongiosis) on basal layer of epidermis with normal 
continuity of epidermo-dermal junction; Dermal mononuclear cell infiltration 10-20 cells / 
500X optic field; Epidermal (especially on epidermo-dermal junction) mononuclear cells 
infiltration  > 3 cells / 200X optic field   
The average grade of limb rejection noted in 35 samples harvested from 13 control rats was 
1.57. In group 2, 126 samples from 32 rats were analyzed. Analyzing the early stages of re-
jection (grade 0 - 2), for corresponding skin graft and limb skin samples, the average grade 
of rejection observed for limb skin was 1.08 compared with 1.46 for the skin grafts. The 
difference in severity of rejection was found to be significant using a paired t test at p <0.005. 
The higher average grade of rejection seen in sentinel skin infers that rejection develops 
sooner at this site. This finding confirms the hypothesis that a distant sentinel skin graft 
rejects before limb skin.  
There was no significant difference using an unpaired t-test (p value = 0.86) between the 
onset of limb skin rejection in groups 1 and 2. The mean rejection grade was 1.57 for group 1 
and 1.42 for group 2. This result confirmed visual analysis, and demonstrated that the 
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sentinel skin graft did not influence the rejection of limb allografts when transplanted 
simultaneously.  
4. Conclusions  
In conclusion, these findings confirm a small, but significant delay in rejection of limb skin 
compared to a DSSG. Skin grafts transplanted simultaneously with a hind limb are thus a 
useful marker of rejection by providing advanced waning of an impending episode. This 
allows earlier intervention with salvage therapy and the consequent rapid initiation of 
therapy that is of benefit in a clinical setting. The DSSG can be placed on a site usually 
covered by clothing and may obviate the need for biopsies of the transplanted limb, with 
their associated scarring, functional and aesthetic consequences. The skin DSSG did not 
appear to significantly alter the incidence of severity of rejection and appear to be safe in 
this animal model. Modifications of the current visual and histopathological criteria for 
diagnosis of rejection were introduced to allow early detection. 
The concept of DSSG is already applied in clinical settings. A series of three hand 
transplants performed where patients received an additional simultaneous full-thickness 
donor skin graft transplanted to the left hip area. This skin was used as a source for skin 
biopsies and as an additional area for monitoring rejection (distant sentinel skin graft, 
DSSG). The DSSG used in all three patients proved to be of benefit, allowing prediction of 
rejection of the hand by as much as 7 days. This allowed appropriate treatment to be started 
immediately. In one patient, salvage therapy (systemic and topical) was delayed until the 
hand showed the same clinical and histological signs of rejection. The skin changes resolved 
completely within 5 days at both locations. In the other two patients salvage therapy was 
started immediately DSSG showed the onset of rejection and rejection of the hand was not 
observed. However, the DSSG was of value only in the early postoperative phases. With 
time DSSG cells were replaced by "creeping substitution" of recipient skin and monitoring 
value was lost.  
In our study, we found that the DSSG showed the first signs of rejection (grade 1), with a 
delay of 1.35 days before the limb skin detection. Sensitivity was reduced to 0.91 days for 
grade 2 rejection. The 7 days interval noted in Italian clinical cases, may be explain by a 
gradual taper of immunosuppressive therapy, rather than the complete withdrawal used in 
this study.  
In the case of the first face transplantation a sentinel radial forearm flap harvested from 
the donor’s left upper limb was transferred to the recipient’s left submammary fold and 
suture end-to-end to the thoracodorsal vessels. This vascularized composite tissue flap, 
hidden under the hanging breast, was used to monitor indirectly the immunological 
behavior of the graft, aiming to avoid damage to the reconstructed face by repeated skin 
biopsies. 
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